000 01826 a2200493 4500
005 20250513231947.0
264 0 _c20010405
008 200104s 0 0 eng d
022 _a0007-0920
024 7 _a10.1054/bjoc.2000.1618
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBijker, N
245 0 0 _aHistological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
_h[electronic resource]
260 _bBritish journal of cancer
_cFeb 2001
300 _a539-44 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCarcinoma, Intraductal, Noninfiltrating
_xgenetics
650 0 4 _aCell Differentiation
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMastectomy, Segmental
650 0 4 _aNeoplasm Invasiveness
_xgenetics
650 0 4 _aNeoplasm Recurrence, Local
_xgenetics
650 0 4 _aPeptide Fragments
_xbiosynthesis
650 0 4 _aReceptor, ErbB-2
_xbiosynthesis
650 0 4 _aReceptors, Estrogen
_xbiosynthesis
650 0 4 _aReceptors, Progesterone
_xbiosynthesis
650 0 4 _aTumor Suppressor Protein p53
_xbiosynthesis
700 1 _aPeterse, J L
700 1 _aDuchateau, L
700 1 _aRobanus-Maandag, E C
700 1 _aBosch, C A
700 1 _aDuval, C
700 1 _aPilotti, S
700 1 _avan de Vijver, M J
773 0 _tBritish journal of cancer
_gvol. 84
_gno. 4
_gp. 539-44
856 4 0 _uhttps://doi.org/10.1054/bjoc.2000.1618
_zAvailable from publisher's website
999 _c11145044
_d11145044